TransMedics Group, Inc.
TMDX
$68.94
$0.090.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 8.19% | 11.78% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.19% | 11.78% | |||
| Cost of Revenue | 8.05% | 13.67% | |||
| Gross Profit | 8.29% | 10.45% | |||
| SG&A Expenses | 22.44% | 11.79% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.16% | 15.74% | |||
| Operating Income | -37.49% | -8.70% | |||
| Income Before Tax | -60.78% | -6.07% | |||
| Income Tax Expenses | 101.40% | -6,402.33% | |||
| Earnings from Continuing Operations | -93.06% | 333.34% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -93.06% | 333.34% | |||
| EBIT | -37.49% | -8.70% | |||
| EBITDA | -13.38% | -3.78% | |||
| EPS Basic | -93.09% | 331.97% | |||
| Normalized Basic EPS | -60.97% | -6.37% | |||
| EPS Diluted | -92.24% | 290.26% | |||
| Normalized Diluted EPS | -55.66% | -6.48% | |||
| Average Basic Shares Outstanding | 0.48% | 0.32% | |||
| Average Diluted Shares Outstanding | -11.57% | 0.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||